But the science is mostly animal-based, small-scale, or too weak to compare to prescription GLP-1 medications
Conclusion Clinical trial data from large, controlled studies demonstrate the efficacy and safety of GLP-1 agonists in terms of A1C reduction, beneficial effects on body weight, and a low risk for hypoglycemic events when used as monotherapy
FEBS Lett 581:29472953 Eydallin G, Montero M, Almagro G, Sesma MT, Viale AM, Muoz FJ, Rahimpour M, Baroja-Fernndez E, Pozueta-Romero J (2010) Genome-wide screening of genes whose enhanced expression affects glycogen accumulation in Escherichia coli
In clinical trials: 2.5% of Wegovy users developed gallbladder-related disorders 1.0% of placebo users developed similar problems Gallstones specifically occurred in 1.6% of Wegovy users vs
People using the drug were four times more likely to experience severe gastrointestinal reactions such as gastroparesis and intestinal blockages
Slowly lower the weights by extending your arms toward the floor